916151-84-3

Upstream product

• 916151-79-6 N-[1-(3,4-dimethoxy-phenyl)-3-hydroxy-propyl]-4-methyl-benzenesulfonamide 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 137845-39-7 N-[1-(3,4-Dimethoxy-phenyl)-meth-(E)-ylidene]-4-methyl-benzenesulfonamide 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 916151-78-5 N-[3-(tert-butyl-dimethyl-silanyloxy)-1-(3,4-dimethoxy-phenyl)-5-hydroxy-oct-7-enyl]-4-methyl-benzenesulfonamide 
• 916151-80-9 N-[3-(4-benzyl-2-oxo-oxazolidin-3-yl)-1-(3,4-dimethoxy-phenyl)-3-oxo-propyl]-4-methyl-benzenesulfonamide 
• 916151-82-1 2-allyl-4-(tert-butyl-dimethyl-silanyloxy)-6-(3,4-dimethoxy-phenyl)-1-(toluene-4-sulfonyl)-piperidine 
• 1026097-20-0 N-[3-(tert-butyl-dimethyl-silanyloxy)-1-(3,4-dimethoxy-phenyl)-5-oxo-pentyl]-4-methyl-benzenesulfonamide 
• 916151-81-0 N-[1-(3,4-dimethoxy-phenyl)-3-hydroxy-hex-5-enyl]-4-methyl-benzenesulfonamide 
• 1026390-27-1 N-[1-(3,4-dimethoxy-phenyl)-3-oxo-propyl]-4-methyl-benzenesulfonamide 
• 916151-76-3 1,2-diallyl-4-(tert-butyl-dimethyl-silanyloxy)-6-(3,4-dimethoxy-phenyl)-piperidine 

Relevant academic research and scientific papers

A concise and enantioselective approach to the total synthesis of (-)-lasubine I

An efficient, enantioselective total synthesis of (-)-lasubine I (1) has been achieved in an overall 8.8% yield from readily available starting materials. The important features of this approach include the creation of stereogenic centers through two sequ